Standard

Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors. / Николаев, Максим; Страшков, Даниил; Рязанцев, Михаил Николаевич; Тихонов, Денис.

в: European Journal of Pharmacology, Том 938, 175448, 05.01.2023.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Николаев, М, Страшков, Д, Рязанцев, МН & Тихонов, Д 2023, 'Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors', European Journal of Pharmacology, Том. 938, 175448. https://doi.org/10.1016/j.ejphar.2022.175448

APA

Николаев, М., Страшков, Д., Рязанцев, М. Н., & Тихонов, Д. (2023). Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors. European Journal of Pharmacology, 938, [175448]. https://doi.org/10.1016/j.ejphar.2022.175448

Vancouver

Николаев М, Страшков Д, Рязанцев МН, Тихонов Д. Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors. European Journal of Pharmacology. 2023 Янв. 5;938. 175448. https://doi.org/10.1016/j.ejphar.2022.175448

Author

Николаев, Максим ; Страшков, Даниил ; Рязанцев, Михаил Николаевич ; Тихонов, Денис. / Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors. в: European Journal of Pharmacology. 2023 ; Том 938.

BibTeX

@article{d90c7bc719d14857a07eb5607d375b2b,
title = "Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors",
abstract = "NMDA receptors play critical roles in numerous physiological and pathological processes in CNS that requires development of modulating ligands. In particular, photoswitchable compounds that selectively target NMDA receptors would be particularly useful for analysis of receptor contributions to various processes. Recently, we identified a light-dependent anti-NMDA activity of the azobenzene-containing quaternary ammonium compounds DENAQ (diethylamine-azobenzene-quaternary ammonium) and DMNAQ (dimethylamine-azobenzene-quaternary ammonium). Here, we developed a series of light-sensitive compounds based on the DENAQ structure, and studied their action on glutamate receptors in rat brain neurons using patch-clamp method. We found that the activities of the compounds and the influence of illumination strongly depended on the structural details, as even minor structural modifications greatly altered the activity and sensitivity to illumination. The compound PyrAQ (pyrrolidine-azobenzene-quaternary ammonium) was the most active and produced fast and fully reversible inhibition of NMDA receptors. The IC50 values under ambient and monochromic light conditions were 2 and 14 μM, respectively. The anti-AMPA activity was much weaker. The action of PyrAQ did not depend on NMDA receptor activity, agonist concentration, or membrane voltage, making it a useful tool for photopharmacological studies.",
keywords = "Inhibition, NMDA receptor, Photopharmacology, Photoswitches",
author = "Максим Николаев and Даниил Страшков and Рязанцев, {Михаил Николаевич} and Денис Тихонов",
year = "2023",
month = jan,
day = "5",
doi = "10.1016/j.ejphar.2022.175448",
language = "English",
volume = "938",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Development of a quaternary ammonium photoswitchable antagonist of NMDA receptors

AU - Николаев, Максим

AU - Страшков, Даниил

AU - Рязанцев, Михаил Николаевич

AU - Тихонов, Денис

PY - 2023/1/5

Y1 - 2023/1/5

N2 - NMDA receptors play critical roles in numerous physiological and pathological processes in CNS that requires development of modulating ligands. In particular, photoswitchable compounds that selectively target NMDA receptors would be particularly useful for analysis of receptor contributions to various processes. Recently, we identified a light-dependent anti-NMDA activity of the azobenzene-containing quaternary ammonium compounds DENAQ (diethylamine-azobenzene-quaternary ammonium) and DMNAQ (dimethylamine-azobenzene-quaternary ammonium). Here, we developed a series of light-sensitive compounds based on the DENAQ structure, and studied their action on glutamate receptors in rat brain neurons using patch-clamp method. We found that the activities of the compounds and the influence of illumination strongly depended on the structural details, as even minor structural modifications greatly altered the activity and sensitivity to illumination. The compound PyrAQ (pyrrolidine-azobenzene-quaternary ammonium) was the most active and produced fast and fully reversible inhibition of NMDA receptors. The IC50 values under ambient and monochromic light conditions were 2 and 14 μM, respectively. The anti-AMPA activity was much weaker. The action of PyrAQ did not depend on NMDA receptor activity, agonist concentration, or membrane voltage, making it a useful tool for photopharmacological studies.

AB - NMDA receptors play critical roles in numerous physiological and pathological processes in CNS that requires development of modulating ligands. In particular, photoswitchable compounds that selectively target NMDA receptors would be particularly useful for analysis of receptor contributions to various processes. Recently, we identified a light-dependent anti-NMDA activity of the azobenzene-containing quaternary ammonium compounds DENAQ (diethylamine-azobenzene-quaternary ammonium) and DMNAQ (dimethylamine-azobenzene-quaternary ammonium). Here, we developed a series of light-sensitive compounds based on the DENAQ structure, and studied their action on glutamate receptors in rat brain neurons using patch-clamp method. We found that the activities of the compounds and the influence of illumination strongly depended on the structural details, as even minor structural modifications greatly altered the activity and sensitivity to illumination. The compound PyrAQ (pyrrolidine-azobenzene-quaternary ammonium) was the most active and produced fast and fully reversible inhibition of NMDA receptors. The IC50 values under ambient and monochromic light conditions were 2 and 14 μM, respectively. The anti-AMPA activity was much weaker. The action of PyrAQ did not depend on NMDA receptor activity, agonist concentration, or membrane voltage, making it a useful tool for photopharmacological studies.

KW - Inhibition

KW - NMDA receptor

KW - Photopharmacology

KW - Photoswitches

UR - https://www.mendeley.com/catalogue/bd26ad1b-f43e-308e-858b-1159bb24e0f1/

U2 - 10.1016/j.ejphar.2022.175448

DO - 10.1016/j.ejphar.2022.175448

M3 - Article

VL - 938

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

M1 - 175448

ER -

ID: 102739046